Cargando…
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Pancreatic cancer is an aggressive malignancy with increasing incidence. Pancreatic ductal adenocarcinoma (PDAC) accounts for > 90% of pancreatic cancer diagnoses, while other exocrine tumors are much rarer. In this review, we have focused on two rare cancers of the exocrine pancreas: adenosquamo...
Autores principales: | Skorupan, Nebojsa, Ghabra, Shadin, Maldonado, J. Alberto, Zhang, Yang, Alewine, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400043/ https://www.ncbi.nlm.nih.gov/pubmed/37538977 http://dx.doi.org/10.20517/2394-4722.2022.106 |
Ejemplares similares
-
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022) -
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022) -
Cystic Neoplasms of the Exocrine
Pancreas
por: Mosimann, F., et al.
Publicado: (1990) -
Diabetes mellitus and the exocrine pancreas.
por: Gorelick, F. S.
Publicado: (1983) -
INTRACISTERNAL GRANULES IN THE EXOCRINE CELLS OF THE PANCREAS
por: Palade, George E.
Publicado: (1956)